Fresenius Medical Care and Galenica are to launch a new renal-focused pharmaceutical company called Vifor-Fresenius Medical Care Renal Pharma to develop treatments for iron deficiency anaemia and bone mineral metabolism for pre-dialysis and dialysis patients.
Galenica and Fresenius form new renal-focused firm
Fresenius Medical Care and Galenica are to launch a new renal-focused pharmaceutical company called Vifor-Fresenius Medical Care Renal Pharma to develop treatments for iron deficiency anaemia and bone mineral metabolism for pre-dialysis and dialysis patients.
More from Cardiovascular
More from Therapeutic Category
• By
Emma Walmsley tells Scrip that the "biotech market is under a certain degree of pressure," so reasonably priced deals are available.
• By
JAK inhibitor gains ninth indication in US after a strong performance in the first quarter.
• By
CSPC’s SYS6010, the first monospecific EGFR-targeting antibody-drug conjugate in the clinic for advanced NSCLC, has shown Phase I promise, but could face close competition with another China-originated bispecific.